Evidence map›Paper›PMID 19324019›Full record

ArticleBiochemical and biophysical research communications2009

IGFBP-3, hypoxia and TNF-alpha inhibit adiponectin transcription.

Giovanna Zappalà, Matthew M Rechler

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Adiponectin and Asthma: Knowns, Unknowns and Controversies.International journal of molecular sciences · 2021
    Review
  5. Article
  6. Review
  7. The Adiponectin Paradox in the Elderly: Associations With Body Composition, Physical Functioning, and Mortality.The journals of gerontology. Series A, Biological sciences and medical sciences · 2019
    Observational
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. IGFBP-3 and TNF-α regulate retinal endothelial cell apoptosis.Investigative ophthalmology & visual science · 2013
    Article
  14. Article
  15. Lymphotoxin-α is a novel adiponectin expression suppressor following myocardial ischemia/reperfusion.American journal of physiology. Endocrinology and metabolism · 2013
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Giovanna ZappalàDiabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892, USA. zappalag@mail.nih.gov
Matthew M Rechler
National Institutes of Health · US

Funding

Regulation of Adiponectin Promoter Activity by IGFBP-3Z01DK055120 · NIDDK · DIABETES, DIGESTIVE, KIDNEY DISEASES · PI RECHLER, MATTHEW M · 2007 to 2007
$273k
Intramural NIH HHS Z01 DK055120
6 · The paper itself

Abstract

The thiazolidinedione rosiglitazone, an agonist ligand for the nuclear receptor PPAR-gamma, improves insulin sensitivity in part by stimulating transcription of the insulin-sensitizing adipokine adiponectin. It activates PPAR-gamma-RXR-alpha heterodimers bound to PPAR-gamma response elements in the adiponectin promoter. Rosiglitazone-stimulated adiponectin protein synthesis in 3T3-L1 mouse adipocytes has been shown to be inhibited by IGFBP-3, which can be induced by hypoxia and the proinflammatory cytokine, TNF-alpha, two inhibitors of adiponectin transcription. The present study demonstrates that IGFBP-3, the hypoxia-mimetic agent cobalt chloride, and TNF-alpha inhibit rosiglitazone-induced adiponectin transcription in mouse embryo fibroblasts that stably express PPAR-gamma2. Native IGFBP-3 can bind RXR-alpha and inhibited rosiglitazone stimulated promoter activity, whereas an IGFBP-3 mutant that does not bind RXR-alpha did not. These results suggest that IGFBP-3 may mediate the inhibition of adiponectin transcription by hypoxia and TNF-alpha, and that IGFBP-3 binding to RXR-alpha may be required for the observed inhibition.

Indexed as

Transcription, Genetic3T3-L1 CellsAdiponectinAnimalsCell HypoxiaCobaltFibroblastsGenes, ReporterHumansHypoglycemic AgentsInsulin-Like Growth Factor Binding Protein 3Insulin ResistanceMiceObesityPPAR gammaRetinoid X Receptor alphaAdiponectinCobaltcobaltous chlorideHypoglycemic AgentsInsulin-Like Growth Factor Binding Protein 3PPAR gammaRetinoid X Receptor alphaRosiglitazoneThiazolidinedionesTumor Necrosis Factor-alpha

Identifiers

PMID19324019
PMCPMC2700779
OpenAlexW1996005560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.